Cyclic peptide-selenium nanoparticles as drug transporters

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3631-3641

  Nasrolahi Shirazi, Amir ^a,b,c   Tiwari, Rakesh K ^a,b,c   Oh, Donghoon ^c   Sullivan, Brian ^c   Kumar, Anil ^c   Beni, Yousef A ^c,d   Parang, Keykavous ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHAPMAN UNIVERSITY   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

antiproliferative; drug delivery; metal; nanoparticle; selenium

Indexed keywords

AMINO ACID DERIVATIVE; CAMPTOTHECIN; CLOFARABINE; CYCLOPEPTIDE; DASATINIB; DOXORUBICIN; DRUG CARRIER; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; IRINOTECAN; METAL NANOPARTICLE; PACLITAXEL; SELENIUM DERIVATIVE; SELENIUM NANOPARTICLE; TRYPTOPHYLARGINYLCYSTEINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; SELENIUM;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL LINE; MASS SPECTROMETRY; NANOENCAPSULATION; OVARIAN CANCER CELL LINE; PEPTIDE SYNTHESIS; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDES, CYCLIC; SELENIUM;

EID: 84907967074     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500364a     Document Type: Article

References (49)

1. Zhang, Y.; Chan, H. F.; Leong, K. W. Advanced materials and processing for drug delivery: The past and the future Adv. Drug Delivery Rev. 2013, 65, 104-120
2. Andrade, F.; Rafael, D.; Videira, M.; Ferreira, D.; Sosnik, A.; Sarmento, B. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases Adv. Drug Delivery Rev. 2013, 65, 1816-1827
3. Mei, L.; Zhang, Z.; Zhao, L.; Huang, L.; Yang, X.-L.; Tang, J.; Feng, S.-S. Pharmaceutical nanotechnology for oral delivery of anticancer drugs Adv. Drug Delivery Rev. 2013, 65, 880-890
4. Swami, A.; Shi, J.; Gadde, S.; Votruba, A. R.; Kolishetti, N.; Farokhzad, O. C. Nanoparticles for Targeted and Temporally Controlled Drug Delivery. In Multifunctional Nanoparticles for Drug Delivery Applications; Springer: New York, 2012; pp 9-29.
5. Ahmad, M. Z.; Akhter, S.; Jain, G. K.; Rahman, M.; Pathan, S. A.; Ahmad, F. J.; Khar, R. K. Metallic nanoparticles: technology overview & drug delivery applications in oncology Expert Opin. Drug Delivery 2010, 7, 927-942
6. Vekariya, K.; Kaur, J.; Tikoo, K. Signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer Nanomed.: Nanotechnol., Biol. Med. 2012, 8, 1125-1132
7. Yang, G.; Zhou, R. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China J. Trace Elem. Electrolytes Health Dis. 1994, 8, 159
8. Sarin, L.; Sanchez, V. C.; Yan, A.; Kane, A. B.; Hurt, R. H. Selenium-carbon bifunctional nanoparticles for the treatment of malignant mesothelioma Adv. Mater. 2010, 22, 5207-5211
9. Wang, D.; Taylor, E. W.; Wang, Y.; Wan, X.; Zhang, J. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention Int. J. Nanomed. 2012, 7, 1711-21
10. Gliga, A. R.; Skoglund, S.; Wallinder, I. O.; Fadeel, B.; Karlsson, H. L. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release Part. Fibre Toxicol. 2014, 11, 11
11. Zhu, J.; Liao, L.; Zhu, L.; Zhang, P.; Guo, K.; Kong, J.; Ji, C.; Liu, B. Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells Talanta 2013, 107, 408-415
12. Liu, W.; Li, X.; Wong, Y.-S.; Zheng, W.; Zhang, Y.; Cao, W.; Chen, T. Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism ACS Nano 2012, 6, 6578-6591
13. Zhang, Y.; Li, X.; Huang, Z.; Zheng, W.; Fan, C.; Chen, T. Enhancement of cell permeabilization apoptosis-inducing activity of selenium nanoparticles by ATP surface decoration Nanomed.: Nanotechnol., Biol. Med. 2012, 9, 74-84
14. Yang, F.; Tang, Q.; Zhong, X.; Bai, Y.; Chen, T.; Zhang, Y.; Li, Y.; Zheng, W. Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles Int. J. Nanomed. 2012, 7, 835-844
15. Wu, H.; Li, X.; Liu, W.; Chen, T.; Li, Y.; Zheng, Y.; Man, C. W.-M.; Wong, M.-K.; Wong, K.-H. Surface decoration of selenium nanoparticles by mushroom polysaccharides-protein complexes to achieve enhanced cellular uptake and antiproliferative activity J. Mater. Chem. 2012, 22, 9602-9610
16. Yu, B.; Zhang, Y.; Zheng, W.; Chen, T. Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles Inorg. Chem. 2012, 51, 8956-8963
17. Langel, U. Cell-Penetrating Peptides: Processes and Applications; CRC Press: Boca Raton, FL, 2002
18. Torchilin, V. P.; Rammohan, R.; Weissig, V.; Levchenko, T. S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Nat. Acad. Sci. U.S.A. 2001, 98, 8786-8791
19. Silhol, M.; Tyagi, M.; Giacca, M.; Lebleu, B.; Vives, E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat Eur. J. Biochem. 2002, 269, 494-501
20. Thorn, P. E.; Persson, D.; Isakson, P.; Goksör, M.; Onfelt, A.; Nordén, B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells Biochem. Biophys. Res. Commun. 2003, 307, 100-107
21. Kim, C. K.; Ghosh, P.; Pagliuca, C.; Zhu, Z.-J.; Menichetti, S.; Rotello, V. M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells J. Am. Chem. Soc. 2009, 131, 1360-1361
22. Mandal, D.; Nasrolahi Shirazi, A.; Parang, K. Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters Angew. Chem., Int. Ed. 2011, 50, 9633-9637
23. Nasrolahi Shirazi, A.; Mandal, D.; Tiwari, R.; Guo, L.; Lu, W.; Parang, K. Cyclic peptide-capped gold nanoparticles as drug delivery systems Mol. Pharmacol. 2012, 10, 500-511
24. Oh, D.; Darwish, S. A.; Shirazi, A. N.; Tiwari, R. K.; Parang, K. Amphiphilic bicyclic peptides as cellular delivery agents ChemMedChem. 2014, 10.1002/cmdc.201402230
25. Nasrolahi Shirazi, A.; Tiwari, R. K.; Brown, A.; Mandal, D.; Sun, G.; Parang, K. Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors Bioorg. Med. Chem. Lett. 2013, 23, 3230-3234
26. Nasrolahi Shirazi, A.; Tiwari, R. K.; Chhikara, B. S.; Mandal, D.; Parang, K. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs Mol. Pharmaceutics 2013, 10, 488-499
27. Tan, Y. N.; Lee, J. Y.; Wang, D. I. C. Uncovering the design rules for peptide synthesis of metal nanoparticles J. Am. Chem. Soc. 2010, 132, 5677-5686
28. Baker, R. D.; Baker, S. S.; Larosa, K.; Whitney, C.; Newburger, P. E. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B Arch. Biochem. Biophys. 1993, 304, 53-57
29. Siddons, R. C.; Mills, C. F. Glutathione peroxidase activity and erythrocyte stability in calves differing in selenium and vitamin E status Br. J. Nutr. 1981, 46, 345-355
30. Li, S.; Shen, Y.; Xie, A.; Yu, X.; Zhang, X.; Yang, L.; Li, C. Rapid, room-temperature synthesis of amorphous selenium/protein composites using Capsicum annuum L extract Nanotechnology 2007, 18, 405101-9
31. Chen, Z.; Shen, Y.; Xie, A.; Zhu, J.; Wu, Z.; Huang, F. l -Cysteine-assisted controlled synthesis of selenium nanospheres and nanorods Cryst. Growth Des. 2009, 9, 1327-1333
32. Bermano, G.; Arthur, J. R.; Hesketh, J. E. Selective control of cytosolic glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase mRNA stability by selenium supply FEBS Lett. 1996, 387, 157-160
33. Garcia-Carbonero, R.; Supko, J. G. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins Cancer Res. 2002, 8, 641-661
34. Slocik, J. M.; Govorov, A. O.; Naik, R. R. Plasmonic circular dichroism of peptide-functionalized gold nanoparticles Nano Lett. 2011, 11, 701-705
35. Petkova, G. A.; Záruba, K.; Zvátora, P.; Králl, V. Gold and silver nanoparticles for biomolecule immobilization and enzymatic catalysis Nanoscale Res. Lett. 2012, 7, 287-297
36. Reid, R. E.; Cariepy, J.; Hodges, R. S. Interaction of neuroleptic drugs with a synthetic calcium-binding peptide analog of site III of rabbit skeletal troponin C. Phenothiazine selective binding FEBS Lett. 1983, 154, 60-64
37. Garcia-Carbonero, R.; Supko, J. G. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins Cancer Res. 2002, 8, 641-661
38. Kailasan, A.; Yuan, Q.; Yang, H. Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D,Llactide) core-shell nanoparticles Acta Biomater. 2009, 6, 1131-1139
39. Mandal, D.; Tiwari, R. K.; Nasrolahi Shirazi, A.; Oh, D.; Ye, G.; Banerjee, A.; Yadav, A.; Parang, K. Self-assembled surfactant cyclic peptide nanostructures as stabilizing agents Soft Matter 2013, 9, 9465-9475
40. Nasrolahi Shirazi, A.; Tiwari, R. K.; Oh, D.; Sullivan, B.; McCaffrey, K.; Mandal, D.; Parang, K. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters Mol. Pharmaceutics 2013, 10, 3137-3151
41. Mandal, D.; Nasrolahi Shirazi, A.; Parang, K. Self-assembly of peptides to nanostructures Org. Biomol. Chem. 2014, 12, 3544-3561
42. Nasrolahi Shirazi, A.; Oh, D.; Tiwari, R. K.; Sullivan, B.; Gupta, A.; Bothun, G. D.; Parang, K. Peptide-amphiphile containing arginine and fatty acyl chains as molecular transporters Mol. Pharmaceutics 2013, 10, 4717-4727
43. Harbaum, L.; Marx, A.; Goekkurt, E.; Schafhausen, P.; Atanackovic, D. Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity Int. J. Hematol. 2013, 99, 91-94
44. Machida, K.; Mayer, B. J. The SH2 domain: versatile signaling module and pharmaceutical target Biochim. Biophys. Acta 2005, 1747, 1-25
45. Nasrolahi Shirazi, A.; Tiwari, R. K.; Oh, D.; Banerjee, A.; Yadav, A.; Parang, K. Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine Mol. Pharmaceutics 2013, 10, 2008-2020
46. Conner, S. D.; Schmid, S. L. Regulated portals of entry into the cell Nature 2003, 422, 37-44
47. Chen, C.-L.; Hou, W. H.; Liu, I. H.; Hsiao, G.; Huang, S. S.; Huang, J. S. Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses J. Cell. Sci. 2009, 122, 1863-1871
48. Hussain, K. M.; Leong, K.L.; Ng, M. M.; Chu, J. J. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71 J. Biol. Chem. 2011, 286, 309-21
49. Oh, D.; Nasrolahi Shirazi, A.; Northup, K.; Sullivan, B.; Tiwari, R. K.; Bisoffi, M.; Parang, K. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization Mol. Pharmaceutics 2014, 11, 2845-2854